http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0496307-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1992-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6d757b176d9746f27abfd440de71fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f250cc9bd47a66dbc45703072283a460
publicationDate 1992-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0496307-A1
titleOfInvention Compositions for intranasal administration comprising sumatriptan
abstract A pharmaceutical composition in a form adapted for intranasal administration comprising 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a physiologically acceptable salt or solvate thereof as active ingredient in the form of a dry powder. n The intranasal compositions are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2691630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1075737-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1598066-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10034857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1598066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004035046-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6613308-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7879358-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6979437-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6391340-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE43711-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0027373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6514482-B1
priorityDate 1991-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2568571-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0122036-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9926171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128419875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227181611

Total number of triples: 45.